The first treatments for COVID-19 could be granted a marketing authorization in the EU as soon as the summer if clinical trial results are positive, but a vaccine is unlikely to be available for another year, according to top executives at the European Medicines Agency.
Using fast-track mechanisms to speed up the development of coronavirus therapeutics and vaccines did not equate to “cutting corners” with...








